Infectious Diseases Society of America position paper: recommended revisions to the National Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) sepsis quality measure.
Open accessThe DOI matches its Crossref record; 101 of the 103 references it cites were found in a registry or an index.
Abstract
The Centers for Medicare & Medicaid Services’ Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) measure has appropriately established sepsis as a national priority. However, the Infectious Diseases Society of America (IDSA and five additional endorsing societies) is concerned about SEP-1’s potential to drive antibiotic overuse because it does not account for the high rate of sepsis overdiagnosis and encourages aggressive antibiotics for all patients with possible sepsis, regardless of the certainty of diagnosis or severity of illness. IDSA is also concerned that SEP-1’s complex “time zero” definition is not evidence-based and is prone to inter-observer variation. In this position paper, IDSA outlines several recommendations aimed at reducing the risk of unintended consequences of SEP-1 while maintaining focus on its evidence-based elements. IDSA’s core recommendation is to limit SEP-1 to septic shock, for which the evidence supporting the benefit of immediate antibiotics is greatest. Prompt empiric antibiotics are often appropriate for suspected sepsis without shock, but IDSA believes there is too much heterogeneity and difficulty defining this population, uncertainty about the presence of infection, and insufficient data on the necessity of immediate antibiotics to support a mandatory treatment standard for all patients in this category. IDSA believes guidance on managing possible sepsis without shock is more appropriate for guidelines that can delineate the strengths and limitations of supporting evidence and allow clinicians discretion in applying specific recommendations to individual patients. Removing sepsis without shock from SEP-1 will mitigate the risk of unnecessary antibiotic prescribing for noninfectious syndromes, simplify data abstraction, increase measure reliability, and focus attention on the population most likely to benefit from immediate empiric broad-spectrum antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several professional societies, including the Infectious Diseases Society of America, have recently encouraged regulators and guideline developers to provide more specific direction about which patients with possible sepsis require immediate broad-spectrum antibiotics, which can safely be managed with narrower spectrum regimens, and which can be managed without antibiotics while obtaining further”
From Trends in empiric broad-Spectrum antibiotic use for suspected community-onset Sepsis in US hospitals (2024) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The three hour window was chosen to match the treatment window recommended by the Centers for Medicare and Medicaid Services (CMS) sepsis core measure (SEP-1) and the Surviving Sepsis Campaign guidelines 36,62,63 .”
From Factors driving provider adoption of the TREWS machine learning-based early warning system and its effects on sepsis treatment timing (2022) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The increasing emphasis on administering immediate antibiotics to all patients with possible sepsis may therefore be driving increased use of unnecessarily broad-spectrum antibiotics, antibiotic-associated adverse events, and antimicrobial resistance without benefitting patients.”
From Trends in empiric broad-Spectrum antibiotic use for suspected community-onset Sepsis in US hospitals (2024) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109 · cited 1×
“IDSA believes a 1-hour treatment target is plausible and justifiable, compared to 3 hours, given the urgency of septic shock [10, 38, 41, 43].”
BackgroundAntibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
A randomized trial of protocol-based care for early septic shock.
The ProCESS Investigators (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401602 · Cited by 2,414
Time to treatment and mortality during mandated emergency care for sepsis.
Seymour, C. W., Gesten, F., Prescott, H. C., Friedrich, M. E., Iwashyna, T. J., Phillips, G. S., Lemeshow, S., Osborn, T., Terry, K. M., & Levy, M. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1703058 · Cited by 2,225 · cited 5×
“There are 2 major lines of evidence that are used to support the mandated roll-out of bundled sepsis care: (1) before/after studies that demonstrate a reduction in sepsis mortality after bundle implementation [51–56]; and/or (2) studies of association that report lower mortality rates in sepsis patients who received b…”
BackgroundResultInfluentialGoal-Directed Resuscitation for Patients with Early Septic Shock
The ARISE Investigators and the ANZICS Clinical Trials Group (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404380 · Cited by 2,028
Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014.
Rhee, C., Dantes, R., Epstein, L., Murphy, D. J., Seymour, C. W., Iwashyna, T. J., Kadri, S. S., Angus, D. C., Danner, R. L., Fiore, A. E., et al. (2017) · JAMA · doi:10.1001/jama.2017.13836 · Cited by 1,884
Self-citation
Cited by
Adams, R., Henry, K. E., Sridharan, A., Soleimani, H., Zhan, A., Rawat, N., Johnson, L., Hager, D. N., Cosgrove, S. E., Markowski, A., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01894-0 · Cited by 365
“Sepsis is highly heterogeneous 24 , and there is evidence that the importance of early antibiotic therapy is similarly heterogeneous 7,25 .”
BackgroundSelf-citationEpidemiology of sepsis and septic shock
Chiu, C., & Legrand, M. (2021) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000958 · Cited by 232
Sepsis: diagnosis and management
Gauer, R. L., Forbes, D. A., & Boyer, N. L. (2024) · Pharmaceutical journal/The pharmaceutical journal · doi:10.1211/pj.2024.1.323850 · Cited by 205
Blood Culture Utilization in the Hospital Setting: a Call for Diagnostic Stewardship
Fabre, V., Carroll, K. C., & Cosgrove, S. E. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.01005-21 · Cited by 180
“the core measure may result in overuse of blood cultures and antibiotics (2).”
BackgroundSelf-citationIm, Y., Kang, D., Ko, R.-E., Lee, Y. J., Lim, S. Y., Park, S., Na, S. J., Chung, C. R., Park, M. H., Oh, D. K., et al. (2022) · Critical Care · doi:10.1186/s13054-021-03883-0 · Cited by 173
Van Heuverswyn, J., Valik, J. K., Desirée van der Werff, S., Hedberg, P., Giske, C., & Nauclér, P. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciac727 · Cited by 163
Henry, K. E., Adams, R., Parent, C., Soleimani, H., Sridharan, A., Johnson, L., Hager, D. N., Cosgrove, S. E., Markowski, A., Klein, E. Y., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01895-z · Cited by 144
Self-citationKaraba, S. M., Jones, G. F., Helsel, T., Smith, L., Avery, R. K., Dzintars, K., Salinas, A. B., Keller, S. C., Townsend, J., Klein, E. Y., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa578 · Cited by 143
Self-citationAntimicrobial Stewardship in the Hospital Setting: A Narrative Review
Giamarellou, H., Galani, L., Karavasilis, T., Ioannidis, K., & Karaiskos, I. (2023) · Antibiotics · doi:10.3390/antibiotics12101557 · Cited by 118
“Recognizing that approximately 50 conditions can mimic sepsis [70], the AS Team should always question whether the patient under discussion is truly infected or not [71].”
BackgroundRhee, C., Yu, T., Wang, R., Kadri, S. S., Fram, D., Chen, H.-C., Klompas, M., & Program, C. P. E. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.38596 · Cited by 81
Self-citationTaylor, S. P., Anderson, W. E., Beam, K., Taylor, B., Ellerman, J., & Kowalkowski, M. A. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000004863 · Cited by 78
“Further, our results support the recent IDSA position that reflexive antibiotic administration for all patients with possible sepsis risks increasing excessive antibiotic utilization without clear benefit (8).”
MethodResultLanckohr, C., & Bracht, H. (2022) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000967 · Cited by 75
Venkatesh, B., Schlapbach, L. J., Mason, D., Wilks, K. M., Seaton, R., Lister, P., Irwin, A., Lane, P., Redpath, L., GIBBONS, K. S., et al. (2021) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2021.100305 · Cited by 72
Shappell, C. N., Klompas, M., Ochoa, A., & Rhee, C. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005090 · Cited by 68
Self-citationBarbash, I. J., Davis, B. S., Yabes, J. G., Seymour, C. W., Angus, D. C., & Kahn, J. M. (2021) · Annals of Internal Medicine · doi:10.7326/m20-5043 · Cited by 65
“Therefore, it is worth considering revisions to the measure that make it more targeted and simpler, such as focusing on early antibiotics for patients with septic shock, in which the benefits may be greatest (10, 11).”
BackgroundPak, T. R., Young, J. G., McKenna, C. S., Agan, A. A., DelloStritto, L. K., Filbin, M. R., Dutta, S., Kadri, S. S., Septimus, E. J., Rhee, C., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad450 · Cited by 64
Self-citationWoo, A., Oh, D. K., Park, C., & Hong, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250101 · Cited by 62
“Considering the risk of overdiagnosis [32], the biomarker of sepsis must be sensitive because of poor clinical outcomes of delayed diagnosis.”
BackgroundAntibiotic Timing and Progression to Septic Shock Among Patients in the ED With Suspected Infection
Bisarya, R., Song, X., Salle, J., Liu, M., Patel, A., & Simpson, S. Q. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.06.029 · Cited by 62
Trends in empiric broad-Spectrum antibiotic use for suspected community-onset Sepsis in US hospitals
Rhee, C., Chen, T., Kadri, S. S., Lawandi, A., Yek, C., Walker, M., Warner, S., Fram, D., Chen, H.-C., Shappell, C. N., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.18923 · Cited by 58
Self-citationLiesenfeld, O., Arora, S., Aufderheide, T. P., Clements, C. M., DeVos, E., Fischer, M., Giamarellos‐Bourboulis, E. J., House, S. L., Humphries, R. L., Gill, J. K., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03933-y · Cited by 49
“…(for example, the Infectious Diseases Society of America) have argued that providers do not have adequate tools to judge who has sepsis, resulting in overtreatment and substantial costs associated with patients given unnecessary antibiotics 34,35 , including the rise of antimicrobial resistance.”
Plasma Microbial Cell-Free DNA Sequencing Technology for the Diagnosis of Sepsis in the ICU
Wang, L., Guo, W., Shen, H., Guo, J., Wen, D., Yu, Y., & Wu, W. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.659390 · Cited by 48
“Therefore, culture-independent technology is required to guide the rational use of antimicrobial drugs (Rhee et al., 2021).”
BackgroundHe, Y. D., Wohlford, E. M., Uhle, F., Buturović, L. J., Liesenfeld, O., & Sweeney, T. E. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080735 · Cited by 46
Li, D., Gai, W., Zhang, J., Cheng, W., Cui, N., & Wang, H. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.816631 · Cited by 44
Validation of SeptiCyte RAPID to Discriminate Sepsis from Non-Infectious Systemic Inflammation
BALK, R. A., Esper, A. M., Martin, G. S., Miller, R. R., Lopansri, B. K., Burke, J. P., Levy, M. M., Opal, S. M., Rothman, R. E., D’Alessio, F. R., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051194 · Cited by 43
“…of the fifteen variables, and performance (sepsis vs. SIRS under the Sepsis-2 framework) was assessed by AUC against consensus RPD. Procalcitonin was included in this analysis, as well as lactate, which is commonly used for determining which patients should receive sepsis treatment bundles [34,35].”
MethodDevelopment and validation of a cellular host response test as an early diagnostic for sepsis
Guillou, L., Sheybani, R., Jensen, A. E., Carlo, D. D., Caffery, T. S., Thomas, C. B., Shah, A. M., Tse, H. T. K., & O’Neal, H. R. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246980 · Cited by 43
Ford, J. S., Morrison, J. C., Kyaw, M., Hewlett, M. M., Tahir, P., Jain, S., Nemati, S., Malhotra, A., & Wardi, G. (2025) · Annals of Internal Medicine · doi:10.7326/annals-24-02426 · Cited by 44
Hooper, G. A., Klippel, C., McLean, S. R., Stenehjem, E. A., Webb, B. J., Murnin, E., Hough, C. L., Bledsoe, J. R., Brown, S. M., & Peltan, I. D. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad101 · Cited by 41
“Various noninfectious conditions, however, can mimic the signs and symptoms of sepsis [8].”
BackgroundRhee, C., Strich, J. R., Chiotos, K., Classen, D. C., Cosgrove, S. E., Greeno, R., Heil, E. L., Kadri, S. S., Kalil, A. C., Gilbert, D. N., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciad447 · Cited by 40
Self-citationAntimicrobial Stewardship in the ICU
Murphy, C. V., Reed, E. E., Herman, D. D., Magrum, B., Beatty, J. J., & Stevenson, K. (2022) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1740977 · Cited by 39
Ryder, J. H., Schooneveld, T. C. V., Diekema, D. J., & Fabre, V. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae479 · Cited by 38
Han, X., Spicer, A. B., Carey, K. A., Gilbert, E. R., Laiteerapong, N., Shah, N. S., Winslow, C. J., Afshar, M., Kashiouris, M. G., & Churpek, M. M. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005054 · Cited by 37
“White 13,871 (54) 6,431 (44) 4,782 (54) 5,052 (43)”
Shappell, C. N., Yu, T., Klompas, M., Agan, A. A., DelloStritto, L. K., Faine, B. A., Filbin, M. R., Mohr, N. M., Park, S. T., Plechot, K., et al. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf118 · Cited by 32
Self-citationRhee, C., Strich, J. R., Klompas, M., Yealy, D. M., & Masur, H. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004305 · Cited by 29
Self-citationLópez‐Cortés, A., Guevara‐Ramírez, P., Kyriakidis, N. C., Barba‐Ostria, C., Cáceres, Á. L., Guerrero, S. X., Ortiz‐Prado, E., Munteanu, C. R., Tejera, E., Cevallos-Robalino, D., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.598925 · Cited by 30
“In addition, the smaller percentage of patients who required mechanical ventilation suffered comorbidities that lead to sepsis and septic shock 75 .”
BackgroundYu, S., Shivakumar, N., Betthauser, K. D., Gupta, A., Lai, A. M., Kollef, M. H., Payne, P., & Michelson, A. P. (2021) · JAMIA Open · doi:10.1093/jamiaopen/ooab062 · Cited by 30
“However, identification of sepsis onset time is not defined in the Sepsis-3 criteria and is prone to disagreement, which can significantly alter the results.(7,12,18) Studies comparing EWS are heterogeneous in their experimental design, especially in identifying the time-at-risk interval from which measurements are ga…”
BackgroundBattle, S., Shuping, M., Withers, S. T., Justo, J. A., Bookstaver, P. B., & Al‐Hasan, M. N. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.12.002 · Cited by 28
Complex Sepsis Presentations, SEP-1 Compliance, and Outcomes
Rhee, C., Train, S. E., Filbin, M. R., Park, S. T., Mohr, N. M., Zepeski, A. E., Faine, B. A., Roach, D. J., Porter, E., Shappell, C. N., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.1100 · Cited by 26
Self-citationSeptimus, E. J. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa220 · Cited by 26
Self-citationBoussina, A. E., Wardi, G., Shashikumar, S. P., Malhotra, A., Zheng, K., & Nemati, S. (2023) · Journal of Medical Internet Research · doi:10.2196/45614 · Cited by 27
“Certain professional societies, including the American College of Emergency Medicine Physicians, have expressed concerns about the current SEP-1 bundle, specifically with regard to quantity of fluid administration and timing of antibiotics in patients without septic shock [5,19].”
The Global Impact of Sepsis: Epidemiology, Recognition, Management, and Health System Challenges
Via, L. L., Ferlito, S., Modica, M. S. D., Marıno, A., Nunnari, G., Cacopardo, B. S., Lechien, J. R., Lentini, M., Lavalle, S., Botto, C. G., et al. (2026) · Epidemiologia · doi:10.3390/epidemiologia7010020 · Cited by 28
“…indicate that strict use of time metrics without the ability to use clinical judgement is linked to over-treatment with broad-spectrum antibiotics, boluses for fluid resuscitation in patients at risk for volume overload, or antibiotics with potential side effects in cases of non-septic SIRS [42].”
Liu, R., Greenstein, J. L., Fackler, J. C., Bembea, M. M., & Winslow, R. L. (2020) · eLife · doi:10.7554/elife.58142 · Cited by 25
“…Disease Society of America’s recently-published recommended revisions to the National Severe Sepsis and Septic Shock Early Management Bundle (Klompas, 2020) recognizes and acknowledges the ambiguity in determining the time of septic shock onset when applying current definitions, and states…”
BackgroundInfluentialUpdated estimates of sepsis hospitalizations at United States academic medical centers
Chan, H. K., Khose, S., Chavez, S., Patel, B., & Wang, H. E. (2022) · Journal of the American College of Emergency Physicians Open · doi:10.1002/emp2.12782 · Cited by 24
Challenging management dogma where evidence is non-existent, weak or outdated
Hofmaenner, D. A., & Singer, M. (2022) · Intensive Care Medicine · doi:10.1007/s00134-022-06659-4 · Cited by 23
Lin, Z., Li, Y., Wu, M., Liu, H., Song, X., Yu, Q., Xiao, G., & Xie, J. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01743-7 · Cited by 22
Prediction of Impending Septic Shock in Children With Sepsis
Liu, R., Greenstein, J. L., Fackler, J. C., Bergmann, J. P., Bembea, M. M., & Winslow, R. L. (2021) · Critical Care Explorations · doi:10.1097/cce.0000000000000442 · Cited by 22
“For example, the Infectious Disease Society of America notes that determining septic shock using adequate fluid resuscitation as part of the criteria results in ambiguity and disagreement on time of onset (43).”
BackgroundO’Neal, H. R., Sheybani, R., Caffery, T. S., Musso, M. W., Hamer, D., Alwood, S. M., Berlinger, M. S., Jagneaux, T., LaVie, K. W., O’Neal, C. S., et al. (2021) · Critical Care Explorations · doi:10.1097/cce.0000000000000460 · Cited by 21
“The identification of a low-risk population that clinicians can safely treat more judiciously is equally as important as the timely identification of high-risk patients who require the recommended, aggressive interventions (29).”
BackgroundEarly management of adult sepsis and septic shock: Korean clinical practice guidelines
Park, C., Ku, N. S., Park, D. W., Park, J. H., Ha, T. S., Kim, D., Park, S. Y., Chang, Y., Jo, K.-W., Baek, M. S., et al. (2024) · Acute and Critical Care · doi:10.4266/acc.2024.00920 · Cited by 20
“…Severe Sepsis and Septic Shock Early Management (SEP-1) bundle, suggesting that sepsis without shock excluded from the bundle treatment, broad-spectrum antibiotics should be started within 1 hour of time zero in septic shock, and the definition of time zero should be clear and reproducible [75].”
Time to administration of antibiotics and mortality in sepsis
Siewers, K., Abdullah, S. M. O. B., Sørensen, R. H., & Nielsen, F. E. (2021) · Journal of the American College of Emergency Physicians Open · doi:10.1002/emp2.12435 · Cited by 21
The 28-Day Mortality Outcome of the Complete Hour-1 Sepsis Bundle in the Emergency Department
Prachanukool, T., Sanguanwit, P., Thodamrong, F., & Suttapanit, K. (2021) · Shock · doi:10.1097/shk.0000000000001815 · Cited by 20
“IDSA revised the National Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) Sepsis Quality Measure in 2020 to only recommend broad-spectrum antibiotics within 1 h in patients with septic shock, and appropriate empiric antibiotics as soon as possible in patients with sepsis but without shock (14).”
MethodAnderson, D. J., Moehring, R. W., Parish, A., David, M. Z., Hsueh, K., Cressman, L., Tolomeo, P., Habrock-Bach, T., Hill, C. L., Ryan, M., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab937 · Cited by 19
Rueda, F. R., Méndez, R., Suárez-de-la-Rica, A., González, R., & Maseda, E. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14010106 · Cited by 17
“Nevertheless, the fact that the antibiotic should be administered in the first few hours is still mandatory in the recommendations of the SSC, although it has led to criticism by the Infectious Diseases Society of America (IDSA) regarding this precocity in patients without shock [126].”
BackgroundSepsis: An Overview of Current Therapies and Future Research
Demir, O., Yöndem, Ö. Z., Yüksel, B. E., & Doğanay, M. (2025) · Journal of Clinical Practice and Research · doi:10.14744/cpr.2025.01903 · Cited by 17
“30”
Gross, B., Donahue, A., Ford, J. S., Lu, X., Boussina, A. E., Malhotra, A., Zheng, K. W., Nemati, S., & Wardi, G. (2025) · Critical Care · doi:10.1186/s13054-025-05493-6 · Cited by 18
“Various professional societies have expressed concerns about rigid time periods for antibiotic administration, particularly when significant diagnostic uncertainty exists [7, 8].”
D’Onofrio, V., Meersman, A., Magerman, K., Waumans, L., van Halem, K., Cox, J., van der Hilst, J. C. H., Cartuyvels, R., Messiaen, P., & Gyssens, I. C. (2021) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2021.106379 · Cited by 17
Real-World Implications of Updated Surviving Sepsis Campaign Antibiotic Timing Recommendations*
Taylor, S. P., Kowalkowski, M. A., SKEWES, S. A., & Chou, S. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006240 · Cited by 16
“The strategy suggested by our real-world data—imple-menting a 1-hour antibiotic target for patients with shock only—is consistent with other data (9–11) and current propositions of some stakeholders including the Infectious Disease Society of America (12).”
ResultZhou, X., Liu, C., Xu, Z., Song, J., Jin, H., Wu, H., Cheng, Q., Deng, W., He, D., Yang, J., et al. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2396569 · Cited by 16
“…in sepsis treatment in recent years, the occurrence of sepsis in infected patients greatly increases the risk of mortality and organ dysfunction [3–5]. therefore, it is vital to accurately assess the severity of the host’s response and the likelihood of disease progression in order to…”
BackgroundMao, J.-Y., Li, D., Zhang, D., Yang, Q., Long, Y., & Cui, N. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09320-1 · Cited by 16
“Therefore, alternative diagnostic strategies, such as metagenomic next-generation sequencing, could complement conventional culture-based methods to enhance infection control measures [7].”
BackgroundBest practice: antibiotic decision-making in ICUs
Brink, A. J., & Richards, G. A. (2020) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000752 · Cited by 16
Effectiveness and Safety of an Emergency Department Code Sepsis Protocol: A Pragmatic Clinical Trial
Peltan, I. D., Bledsoe, J. R., Jacobs, J. R., Groat, D., Klippel, C., Adamson, M., Hooper, G. A., Tinker, N. J., Foster, R. A., Stenehjem, E. A., et al. (2024) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202403-286oc · Cited by 15
“…increasing unnecessary or unnecessarily broad-spectrum antibiotics and thereby causing patient-and population-level antibiotic adverse effects, including C. dif fi cile infection, allergic reactions and other antibiotic treatment complications, and antibiotic resistance (24, 25, 55, 56).”
Trial of antibiotic restraint in presumed pneumonia: A Surgical Infection Society multicenter pilot
Guidry, C. A., Beyene, R. T., Watson, C. M., Sawyer, R. G., Chollet‐Hinton, L., Simpson, S. Q., Atchison, L., Derickson, M. J., Cooper, L., Pennington, G. P., et al. (2022) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000003839 · Cited by 14
Baghdadi, J. D., Goodman, K. E., Magder, L. S., Claeys, K. C., Sutherland, M. E., & Harris, A. D. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf039 · Cited by 15
Rhee, C., Li, Z., Wang, R., Song, Y., Kadri, S. S., Septimus, E. J., Chen, H.-C., Fram, D. M., Jin, R., Poland, R., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa213 · Cited by 14
“The high burden of sepsis has spurred national efforts to improve timely treatment and bundle adherence, including the Centers for Medicare & Medicaid Services (CMS) Severe Sepsis/Septic Shock Early Management Bundle (SEP-1) that was implemented in 2015 [3, 4].”
BackgroundSelf-citationThe CDC antimicrobial use measure is not ready for public reporting or value-based programs
Shively, N. R., & Morgan, D. J. (2023) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2023.143 · Cited by 14
“19 Although well intended, these examples should serve as warnings that national requirements that precede a firm evidence base can lead to wasteful or harmful patient care and unnecessary administrative burden.”
Early Empirical Use of Broad-Spectrum Antibiotics in Sepsis
Chang, J. L., Pearson, J. C., & Rhee, C. (2022) · Current Infectious Disease Reports · doi:10.1007/s11908-022-00777-2 · Cited by 13
Self-citationAntimicrobial ethicists: Making ethics explicit in antimicrobial stewardship
Yen, C. F., & Cutrell, J. B. (2021) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2021.181 · Cited by 13
Perceptions of Health Care–Associated Infection Metrics by Infection Control Experts
Schrank, G. M., Branch‐Elliman, W., Leekha, S., Baghdadi, J. D., Pineles, L. L., Harris, A. D., & Morgan, D. J. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.8952 · Cited by 13
Aita, T., Nakagawa, H., Takahashi, S., Naganuma, T., Anan, K., Banno, M., & Hamaguchi, S. (2024) · BMC Medicine · doi:10.1186/s12916-024-03467-z · Cited by 12
“Regarding sepsis, the relationship between prompt antimicrobial treatment and clinical outcomes remains controversial [52].”
BackgroundOptimal antibiotic use in the intensive care unit
Micek, S. T., Vazquez Guillamet, M. C., Reynolds, D., Matuszak, S., Kolodziej, L., & Kollef, M. H. (2025) · Critical Care · doi:10.1186/s13054-025-05653-8 · Cited by 11
“This differentiation led IDSA to caution against blanket recommendations for Rapid antibiotics in all sepsis cases, favoring a Rapid evaluation within the first 3−5 hours [21, 22].”
Revising Sepsis Definitions to Better Target and Tailor Sepsis Care
Klompas, M., & Rhee, C. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf187 · Cited by 11
Self-citationSong, B., Fu, K., Zheng, X., & Liu, C. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1543586 · Cited by 12
Figueiredo-Pereira, C., Fleming, P., Alganes, M. N., Bi, R., Cavaleiro, A. M., CRUZ, D. Z. D. N., Cunha-Matos, C., Davalos-Arias, M., Farkas, D., Hasin-Brumshtein, Y., et al. (2025) · Journal of Clinical Microbiology · doi:10.1128/jcm.00352-25 · Cited by 11
Timing and Spectrum of Antibiotic Treatment for Suspected Sepsis and Septic Shock
Pak, T. R., Rhee, C., & Klompas, M. (2022) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2022.08.001 · Cited by 11
Self-citationBolanaki, M., Kurland, L., Brabrand, M., Daniels, R., Govender, K., Hanses, F., Innocenti, F., Lassen, A. T., Martín‐Loeches, I., & Möckel, M. (2025) · European Journal of Emergency Medicine · doi:10.1097/mej.0000000000001255 · Cited by 10
“This approach balances the need for timely intervention with concerns about inappropriate or excessive broad-spectrum antibiotic use in an era of rising antimicrobial resistance [21,22].”
Management of Sepsis in Hospitalized Patients
Palakshappa, J. A., & Taylor, S. P. (2025) · Annals of Internal Medicine · doi:10.7326/annals-25-02685 · Cited by 10
A Quantitative Study of Decision Thresholds for Initiation of Antibiotics in Suspected Sepsis
Taylor, S. P., Weissman, G. E., Kowalkowski, M. A., Admon, A. J., SKEWES, S. A., Xia, Y., & Chou, S.-H. (2022) · Medical Decision Making · doi:10.1177/0272989x221121279 · Cited by 10
Bacterial Coinfection in COVID-19 and Influenza Pneumonia
Musher, D. M. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202106-1467ed · Cited by 10
Syndromic Analysis of Sepsis Cohorts Using Large Language Models
Pak, T. R., Kanjilal, S., McKenna, C. S., Hoffner-Heinike, A., Rhee, C., & Klompas, M. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.39267 · Cited by 9
Self-citationHerndon, J. M., Blackwell, S. B., Pinner, N. A., Achey, T. S., Holder, H. B., & Tidwell, C. (2024) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2024.02.001 · Cited by 9
Ablordeppey, E., Zhao, A., Ruggeri, J., Hassan, A., Wallace, L., Agarwal, M., Stickles, S. P., Holthaus, C. V., & Theodoro, D. L. (2024) · Emergency Medicine International · doi:10.1155/2024/5675066 · Cited by 9
“…sepsis or septic shock, we restricted inclusion to patients who had both Centers for Medicare and Medicaid Services (CMSs) Severe Sepsis/Septic Shock (SEP-1) fuid requirement criteria of 30cc/kg fuid bolus within 3hours of presentation: a lactate ≥ 4 and hypotension (SBP 90 or MAP 65) [28, 29].”
MethodEstrategia integral de reanimación del paciente con sepsis y shock séptico
del Río-Carbajo, L., Olmo, J. N.-D., Fernández‐Ugidos, P., & Vidal, P. (2022) · Medicina Intensiva · doi:10.1016/j.medin.2022.02.003 · Cited by 9
Xie, X., Huo, L., Zhao, L., & Qian, Y. (2023) · Communications in Theoretical Physics · doi:10.1088/1572-9494/acce31 · Cited by 9
“Diseases are a serious threat to human society, for example, COVID-19, tuberculosis and influenza may cause many disasters to public security and individuals’ health [1].”
Zhu, Q.-T., Wang, H., Chen, L., Yu, Y., & Chen, M. (2024) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2024.e00444 · Cited by 8
August, B., Griebe, K. M., Stine, J. J., Hauser, C. D., Hunsaker, T., Jones, M. C., Martz, C. R., Peters, M. A., To, L., Belanger, R., et al. (2022) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2715 · Cited by 8
Tripathi, R. K., Kenaa, B., Claeys, K. C., Johnson, J. K., Patel, M., Atkinson, J., Maldarelli, M. E., Newman, M., & Leekha, S. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae500 · Cited by 7
Kondo, Y., Klompas, M., McKenna, C. S., Pak, T. R., Shappell, C. N., DelloStritto, L. K., & Rhee, C. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae599 · Cited by 7
Self-citationEarly detection of ICU-acquired infections using high-frequency electronic health record data
Varkila, M. R. J., Lancia, G., van Smeden, M., Bonten, M. J. M., Spitoni, C., & Cremer, O. L. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-025-03031-6 · Cited by 7
“Performing diagnostic bundles or molecular tests when model predictions indicate increased risk of ICU-AI could provide additional evidence of infection and assist in further decision making [25–28].”
Treating Sepsis in Patients with Heart Failure
Winterbottom, F. A. (2022) · Critical Care Nursing Clinics of North America · doi:10.1016/j.cnc.2022.02.006 · Cited by 7
Daering, N. J., & Al‐Hasan, M. N. (2022) · Exploration of Immunology · doi:10.37349/ei.2022.00075 · Cited by 7
“The Infectious Disease Society of America’s (IDSA’s) position paper on SEP-1, in fact, expressed concern that mandatory sepsis bundles would exacerbate broad-spectrum antibiotic use [30].”
BackgroundWilks, K. M., Mason, D., Rice, M., Seaton, R., Redpath, L., GIBBONS, K. S., Ergetu, E., Lane, P., & Venkatesh, B. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-072167 · Cited by 7
Lawrence, J., Lee, B. S., Fadahunsi, A. I., & Mowery, B. D. (2024) · Journal of Nursing Care Quality · doi:10.1097/ncq.0000000000000767 · Cited by 7
“23 Lastly, broad-spectrum antibiotic administration within 3 hours of severe sepsis presentation was not a significant predictor of positive patient outcomes in this study.”
BackgroundLee, A. H.-Y., Aaronson, E. L., Hibbert, K. A., Flynn, M. H., Rutkey, H., Mort, E. A., Sonis, J. D., & Safavi, K. C. (2021) · Journal of Medical Internet Research · doi:10.2196/26946 · Cited by 7
“There has been argument in the literature about the appropriateness of some components of the bundle [8-10]; however, the fact remains that early identification and treatment of patients with sepsis remains an important quality opportunity.”
BackgroundYin, Y., Shen, J., Du, Z., Wang, B., Wang, G., Chen, H., Wang, J., An, Y., Liu, C., & Wang, H. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003175 · Cited by 6
“[1] Despite advances in diagnostic technology, clinicians are still unable to detect the origin of sepsis in approximately one-quarter (28”
Gao, Y., Zeng, M., Huang, K., & Li, G. (2025) · Microchimica Acta · doi:10.1007/s00604-025-07498-y · Cited by 6
“Precise identification of infectious pathogens is critical for improving patient care, selecting appropriate therapies, and preventing infection spread [216].”
Physician Variation in Early Sepsis Management
Peltan, I. D., Groat, D., Butler, J., Bledsoe, J. R., Ofori-Atta, B. S., Wu, C., Presson, A. P., Greene, T. H., Christensen, M. A., Schroeder, F. M., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.56945 · Cited by 6
Faust, J. S. (2021) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2021.03.003 · Cited by 6
The Emergency Medicine Pharmacotherapy Literature of 2021
Brown, C. S., Sarangarm, P., Faine, B. A., Rech, M. A., Flack, T., Gilbert, B. W., Howington, G. T., Laub, J., Porter, B. A., Slocum, G. W., et al. (2022) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2022.07.039 · Cited by 6
Kim, J. H., Kim, Y. K., Oh, D. K., Jeon, K., Ko, R., Suh, G. Y., Lim, S. Y., Lee, Y. J., Cho, Y., Park, M.-H., et al. (2022) · Shock · doi:10.1097/shk.0000000000002067 · Cited by 6
“Different populations or healthcare systems may impact clinical practice patterns and patient outcomes (33).”
BackgroundSepsis endotypes: The early bird still gets the worm
Varon, J., & Baron, R. M. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103832 · Cited by 6
Sanguanwit, P., Monthonn, C., Prachanukool, T., & Suttapanit, K. (2022) · International Journal of Emergency Medicine · doi:10.1186/s12245-022-00416-6 · Cited by 6
Antibiotic Administration and Timing: Risks, Delay, Zombies*
Townsend, S. R. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005151 · Cited by 6
Metadata
- Authors
- Rhee, C., Chiotos, K., Cosgrove, S. E., Heil, E. L., Kadri, S. S., Kalil, A. C., Gilbert, D. N., Masur, H., Septimus, E. J., Sweeney, D. A., Strich, J. R., Winslow, D. L., & Klompas, M.
- Affiliations
- Brigham and Women's Hospital (US)
- Children's Hospital of Philadelphia (US)
- Johns Hopkins University (US)
- University of Maryland, Baltimore (US)
- National Institutes of Health (US)
- Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska School of Medicine, Omaha, Nebraska, USA
- Oregon Health & Science University (US)
- Harvard University (US)
- University of California San Diego (US)
- Stanford Medicine (US)
- Corresponding author
- Masur, Henry
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-06
- Volume
- 72
- Issue
- 4
- Pages
- 541-552
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC8189682
- OpenAlex
- W3023620462
- Cited by
- 191
- References
- 103
- Citations by year
- 2026: 14 · 2025: 31 · 2024: 36 · 2023: 20 · 2022: 31 · 2021: 47 · 2020: 12
- FWCI
- 19.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Keywords
- sepsis, septic shock, Centers for Medicare and Medicaid Services, antibiotic overuse, empirical antibiotic therapy, interobserver variability, broad-spectrum antibiotics
- MeSH terms
- Aged, Anti-Bacterial Agents, Communicable Diseases, Medicare, Humans, Shock, Septic, United States, Reproducibility of Results, Sepsis, Quality Indicators, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.